Padagis Us Drug Patent Portfolio

Padagis Us owns 5 orange book drugs protected by 10 US patents with Butoconazole Nitrate having the least patent protection, holding only 1 patent. And Evamist with maximum patent protection, holding 4 patents. Given below is the list of Padagis Us's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9789057 Pharmaceutical delivery system 02 Dec, 2026
Active
US6899890 Bioadhesive drug delivery system 27 Apr, 2023 Expired
US6978945 Dispensing device 30 Nov, 2021 Expired
US6013657 Pharmaceutical compositions containing mupirocin 08 Jul, 2018 Expired
US5993856 Pharmaceutical preparations and methods for their administration 17 Nov, 2017 Expired
US6299900 Dermal penetration enhancers and drug delivery systems involving same 19 Feb, 2017 Expired
US6818226 Dermal penetration enhancers and drug delivery systems involving same 19 Feb, 2017 Expired
US6923983 Transdermal delivery of hormones 19 Feb, 2017 Expired
US5643602 Oral composition for the treatment of inflammatory bowel disease 01 Jan, 2015 Expired
US5643602 Oral composition for the treatment of inflammatory bowel disease 01 Jul, 2014 Expired


Given below is the list of recent legal activities going on the following drug patents of Padagis Us.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 4th Year, Large Entity 07 Apr, 2021 US9789057
Notice of Final Determination -Election Required 09 Jan, 2019 US6818226
FDA Final Eligibility Letter 19 Mar, 2018 US6818226
Interim Patent Term Extension Granted 31 Jan, 2018 US6818226
Recordation of Patent Grant Mailed 17 Oct, 2017 US9789057
Patent Issue Date Used in PTA Calculation 17 Oct, 2017 US9789057
Issue Notification Mailed 27 Sep, 2017 US9789057
Dispatch to FDC 13 Sep, 2017 US9789057
Application Is Considered Ready for Issue 12 Sep, 2017 US9789057
Issue Fee Payment Verified 11 Sep, 2017 US9789057
Issue Fee Payment Received 11 Sep, 2017 US9789057
Entity Status Set To Undiscounted (Initial Default Setting or Status Change) 06 Sep, 2017 US9789057
Expire Patent 28 Aug, 2017 US6923983
transaction for FDA Determination of Regulatory Review Period 21 Aug, 2017 US6818226
Mail Notice of Allowance 12 Jun, 2017 US9789057


Padagis Us's Drug Patent Litigations

Padagis Us's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Sep 04, 2014, against patent number US9789057. The petitioner , challenged the validity of this patent, with Thomas C. Riley et al as the respondent. Click below to track the latest information on how companies are challenging Padagis Us's patents.

Patent Proceeding Filing Date Status Respondent Petitioner
Patent litigations
US9789057 September, 2014 Decision
(23 Mar, 2017)
Thomas C. Riley et al


Padagis Us's Family Patents

Padagis Us drugs have patent protection in a total of 21 countries. It's US patent count contributes only to 18.2% of its total global patent coverage. 14 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Padagis Us Drug List

Given below is the complete list of Padagis Us's drugs and the patents protecting them.


1. Butoconazole Nitrate

Butoconazole Nitrate is protected by 1 patent, which has expired already. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5993856 Pharmaceutical preparations and methods for their administration 17 Nov, 2017
(7 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Butoconazole Nitrate's drug page


2. Centany

Centany is protected by 1 patent, which has expired already. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6013657 Pharmaceutical compositions containing mupirocin 08 Jul, 2018
(6 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Centany's drug page


3. Clindesse

Clindesse is protected by 3 patents, out of which 2 have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9789057 Pharmaceutical delivery system 02 Dec, 2026
(2 years from now)
Active
US6899890 Bioadhesive drug delivery system 27 Apr, 2023
(1 year, 6 months ago)
Expired
US5993856 Pharmaceutical preparations and methods for their administration 17 Nov, 2017
(7 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Clindesse's drug page


4. Entocort Ec

Entocort Ec is protected by 2 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5643602
(Pediatric)
Oral composition for the treatment of inflammatory bowel disease 01 Jan, 2015
(9 years ago)
Expired
US5643602 Oral composition for the treatment of inflammatory bowel disease 01 Jul, 2014
(10 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Entocort Ec's drug page


5. Evamist

Evamist is protected by 4 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6978945 Dispensing device 30 Nov, 2021
(2 years ago)
Expired
US6299900 Dermal penetration enhancers and drug delivery systems involving same 19 Feb, 2017
(7 years ago)
Expired
US6818226 Dermal penetration enhancers and drug delivery systems involving same 19 Feb, 2017
(7 years ago)
Expired
US6923983 Transdermal delivery of hormones 19 Feb, 2017
(7 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Evamist's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List